HK1208054A1 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof - Google Patents

Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

Info

Publication number
HK1208054A1
HK1208054A1 HK15108691.8A HK15108691A HK1208054A1 HK 1208054 A1 HK1208054 A1 HK 1208054A1 HK 15108691 A HK15108691 A HK 15108691A HK 1208054 A1 HK1208054 A1 HK 1208054A1
Authority
HK
Hong Kong
Prior art keywords
stem cells
mesenchymal
methods
human embryonic
embryonic stem
Prior art date
Application number
HK15108691.8A
Other languages
English (en)
Chinese (zh)
Inventor
王小方
徐仁和
Original Assignee
Imstem Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49916651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1208054(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Imstem Biotechnology Inc filed Critical Imstem Biotechnology Inc
Publication of HK1208054A1 publication Critical patent/HK1208054A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0692—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK15108691.8A 2012-07-12 2015-09-07 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof HK1208054A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261670787P 2012-07-12 2012-07-12
US201361762961P 2013-02-11 2013-02-11
PCT/US2013/048291 WO2014011407A2 (fr) 2012-07-12 2013-06-27 Cellules souches de type mésenchymateuses issues de cellules souches embryonnaires humaines, leurs procédés et leurs utilisations

Publications (1)

Publication Number Publication Date
HK1208054A1 true HK1208054A1 (en) 2016-02-19

Family

ID=49916651

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108691.8A HK1208054A1 (en) 2012-07-12 2015-09-07 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

Country Status (5)

Country Link
US (3) US9745551B2 (fr)
CN (1) CN104471059B (fr)
CA (1) CA2876499C (fr)
HK (1) HK1208054A1 (fr)
WO (1) WO2014011407A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2377925A1 (fr) 2006-04-14 2011-10-19 Advanced Cell Technology, Inc. Cellules formant colonie d'hemangio
DK2785359T3 (en) * 2011-11-30 2018-10-29 Astellas Inst For Regenerative Medicine MESENKYMAL STROMACELLES AND APPLICATIONS RELATED
JP6114840B2 (ja) * 2013-03-01 2017-04-12 アプセト ゲーエムベーハー アンド ツェーオー．カーゲー ヒトｃｄ３４陰性前駆細胞による免疫に媒介される細胞傷害性反応からの血管内皮の保護
EP3105587B1 (fr) * 2014-02-11 2023-09-06 Brainstorm Cell Therapeutics Ltd. Procédé de qualification de cellules
EP3162156B1 (fr) 2014-06-27 2020-04-22 Techflux Inc. Procédé et dispositif de transmission d'une unité de données
US10550187B2 (en) * 2014-10-24 2020-02-04 Incept, Llc Extra luminal scaffold
CN105769911A (zh) * 2016-03-23 2016-07-20 中国人民解放军第二军医大学 间充质干细胞诱导斑秃处毛发再生的方法及应用
JP2020509773A (ja) * 2017-03-17 2020-04-02 センティ バイオサイエンシズ インコーポレイテッド 免疫調節性細胞回路
EP4317422A3 (fr) 2017-04-13 2024-05-01 Senti Biosciences, Inc. Immunothérapie anticancéreuse combinatoire
SG11201912200YA (en) * 2017-06-16 2020-01-30 Cynata Therapeutics Ltd Method for treating a side effect of immunotherapy
EP3681519A4 (fr) * 2017-09-15 2021-04-28 Cynata Therapeutics Limited Procédé de traitement d'une maladie allergique des voies respiratoires (aad)/de l'asthme
WO2019053295A1 (fr) * 2017-09-18 2019-03-21 Fundació Institut D'investigació Sanitària Pere Virgili Procédés pour améliorer l'efficacité d'une thérapie cellulaire avec des populations de cellules souches mésenchymateuses
CN109666630A (zh) * 2017-10-17 2019-04-23 澳门大学 多能干细胞分化为间充质干细胞的方法及其培养基和应用
CA3082368A1 (fr) * 2017-11-09 2019-05-16 Sapporo Medical University Produit medicinal pour une regeneration tissulaire, et son procede de preparation
EP3717629A1 (fr) * 2017-11-28 2020-10-07 Inno-Health Technology Co., Ltd. Méthodes de production de populations de cellules souches mésenchymateuses à partir de sang périphérique et leurs utilisations
KR102096150B1 (ko) * 2018-01-05 2020-04-02 재단법인 아산사회복지재단 인터페론 감마로 전처리된 유도만능 줄기세포 유래 중간엽 줄기세포 및 이로부터 유래된 엑소좀을 포함하는 피부질환의 개선, 예방 또는 치료용 조성물
CN108646030B (zh) * 2018-06-04 2020-12-22 中国医学科学院北京协和医院 一种大动脉炎检测的生物标志物面板及其用途
EP3866813A4 (fr) 2018-10-17 2022-08-03 Senti Biosciences, Inc. Immunothérapie anticancéreuse combinatoire
US11419898B2 (en) 2018-10-17 2022-08-23 Senti Biosciences, Inc. Combinatorial cancer immunotherapy
US11697799B2 (en) * 2019-04-15 2023-07-11 Ossium Health, Inc. System and method for extraction and cryopreservation of bone marrow
JP2022542247A (ja) * 2019-07-24 2022-09-30 エスエルバイジェン インコ―ポレイテッド 不死化幹細胞株の製造方法およびその用途
EP3909594A1 (fr) * 2020-05-14 2021-11-17 Bernat Soria Escoms Cellules souches mésenchymateuses pour le traitement de covid-19 et autres maladies inflammatoires, auto-immunes et dégénératives
CN111979187B (zh) * 2020-08-21 2022-04-08 遵义医科大学附属医院 一种抗人间充质干细胞衰老及增强其干性特征的方法
CN114457033A (zh) * 2020-10-30 2022-05-10 未来智人再生医学研究院(广州)有限公司 一种表达il-6阻断物的多能干细胞衍生物及其应用
CN112748080A (zh) * 2020-12-25 2021-05-04 北京泽辉辰星生物科技有限公司 满足产品放行要求的免疫调节干细胞ido1活性检测方法
CN114752688B (zh) * 2022-04-28 2024-02-23 北京大学口腔医学院 鉴定人类胚胎骨髓来源的间充质干细胞的方法、探针和试剂盒及其用途
CN114752559B (zh) * 2022-06-14 2022-09-02 北京国卫生物科技有限公司 一种人胎盘绒毛膜间充质干细胞的分离培养扩增方法
CN114984051A (zh) * 2022-06-27 2022-09-02 广州惠善医疗技术有限公司 间充质干细胞在制备治疗炎症及免疫相关疾病的药物中的应用
CN116836920B (zh) * 2023-08-21 2024-05-24 广东横琴粤澳深度合作区齐美国际干细胞医院有限公司 一种无血清培养基及其制备间充质干细胞的方法
CN117778313B (zh) * 2024-02-23 2024-05-24 成都云测医学生物技术有限公司 脑类器官获得间充质干细胞分化方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2329519A1 (fr) * 1998-06-08 1999-12-16 Osiris Therapeutics, Inc. Conservation in vitro de cellules souches hematopoietiques
AR047712A1 (es) * 2002-09-07 2006-02-15 Royal Veterinary College Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas
WO2005063303A1 (fr) * 2003-12-19 2005-07-14 Viacell, Inc. Utilisation de cellules souches pluripotentes derivees de sang ombilical humain pour le traitement de maladies
US7592176B2 (en) * 2004-05-07 2009-09-22 Wisconsin Alumni Research Foundation Method of forming mesenchymal stem cells from embryonic stem cells
JP2010500047A (ja) * 2006-08-15 2010-01-07 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 間葉系幹細胞馴化培地
US7615374B2 (en) 2007-09-25 2009-11-10 Wisconsin Alumni Research Foundation Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions
US20110236971A2 (en) 2007-09-25 2011-09-29 Maksym Vodyanyk Generation of Clonal Mesenchymal Progenitors and Mesenchymal Stem Cell Lines Under Serum-Free Conditions
WO2009104825A1 (fr) * 2008-02-18 2009-08-27 Kaist Procédé pour induire la différenciation de cellules souches embryonnaires en hémangioblaste
AU2010229872A1 (en) * 2009-03-26 2011-11-03 The Regents Of The University Of California Mesenchymal stem cells producing inhibitory RNA for disease modification
WO2011047345A2 (fr) * 2009-10-15 2011-04-21 Tai June Yoo Méthodes de traitement de maladies ou d'affections faisant appel à des cellules souches mésenchymateuses
CN102791276B (zh) * 2010-03-10 2015-03-04 智再如股份有限公司 含有间充质干细胞的细胞制品及其制造方法
WO2011124741A1 (fr) * 2010-04-08 2011-10-13 Fundación Progreso Y Salud Utilisation d'un milieu de culture conditionné par des cellules souches mésenchymateuses pour la différenciation de cellules souches pluripotentes humaines
JP5805195B2 (ja) * 2010-08-23 2015-11-04 カンステム バイオテック カンパニー リミテッド Ｎｏｄ２アゴニストで処理した幹細胞またはその培養物を含む免疫疾患および炎症性疾患の予防および治療用の薬学的組成物
DK2785359T3 (en) 2011-11-30 2018-10-29 Astellas Inst For Regenerative Medicine MESENKYMAL STROMACELLES AND APPLICATIONS RELATED
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto

Also Published As

Publication number Publication date
US10557122B2 (en) 2020-02-11
US9745551B2 (en) 2017-08-29
CN104471059B (zh) 2018-04-17
CA2876499C (fr) 2021-10-26
CN104471059A (zh) 2015-03-25
US20150203820A1 (en) 2015-07-23
WO2014011407A2 (fr) 2014-01-16
CA2876499A1 (fr) 2014-01-16
US20180010098A1 (en) 2018-01-11
WO2014011407A3 (fr) 2014-04-17
US20200392463A1 (en) 2020-12-17

Similar Documents

Publication Publication Date Title
HK1208055A1 (en) Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
HK1208054A1 (en) Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
HK1253909A1 (zh) 免疫缺陷的經遺傳修飾的嚙齒類及其使用方法
HK1208165A1 (en) Drug-conjugates, conjugation methods, and uses thereof
HK1254894A1 (zh) 自動駕駛儀及其方法
SG11201500329WA (en) Stem cell microparticles
SG11201406336YA (en) Stem cell microparticles
HK1203449A1 (en) Azetidinium-containing copolymers and uses thereof
GB201200075D0 (en) Grf3 mutants, methods and plants
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
AP2015008594A0 (en) Continuous extractor, concentrator and dryer
HK1210913A1 (en) Particles, methods and uses thereof
EP2863736A4 (fr) Animaux génétiquement modifiés et procédés de production associés
GB201201100D0 (en) Polypeptides and methods
HK1210949A1 (en) Combinations and uses thereof
HK1214624A1 (zh) 心臟幹細胞和其識別方法和用途
EP2797436A4 (fr) Boissons à base de plantes et leurs procédés de préparation
EP2837627A4 (fr) Dérivé d'amidopyridine, et son utilisation
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
HUE041320T2 (hu) 1,3-Specifikus intraészterezés
IL234459B (en) Facilities and methods for selecting cells resistant to apoptotic marking and their use
EP2938196A4 (fr) Cellules souches placentaires résistantes à l'anoikis et leurs utilisations
EP2900693A4 (fr) Anticorps médiant adcc, combinaisons et applications associées
SG11201502980VA (en) POLYPEPTIDES DERIVED FROM TGFβ AND USES THEREOF
GB201217826D0 (en) The Baubury beehive and slotted base